Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3448
  • Home
  • Print this page
  • Email this page

   Table of Contents      
LETTER TO THE EDITOR
Year : 2014  |  Volume : 62  |  Issue : 1  |  Page : 96-97

Authors' reply


1 Department of Ophthalmology, Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey
2 Department of Cardiology, Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey
3 Department of Endocrinology and Metabolism, Internal Medicine, Duzce University Medical Faculty, Duzce, Turkey

Date of Web Publication31-Jan-2014

Correspondence Address:
H I Onder
Department of Ophthalmology, Duzce University Medical Faculty, Konuralp 81160, Duzce
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.126195

Rights and Permissions

How to cite this article:
Onder H I, Kilic A C, Kaya M, Bulur S, Onder E, Tunc M. Authors' reply. Indian J Ophthalmol 2014;62:96-7

How to cite this URL:
Onder H I, Kilic A C, Kaya M, Bulur S, Onder E, Tunc M. Authors' reply. Indian J Ophthalmol [serial online] 2014 [cited 2020 Aug 4];62:96-7. Available from: http://www.ijo.in/text.asp?2014/62/1/96/126195

Dear Sir,

We thank the authors for their interest in our article [1] and appreciate their comments.

Briefly, all subjects underwent detailed physical examination in our study. Our exclusion criteria included history of diabetes, glaucoma, blood dyscrasias, renal failure, hepatic disorders, malignancy, and history of drug use (non-steroid anti-inflammatory drugs, anti-coagulant medications, and oral contraceptives). Patients with branched retinal vein occlusion (BRVO) who had a history of vasculitis were also excluded from the study. We found that mean platelet volume (MPV) is significantly higher in hypertensive patients with BRVO than control group (hypertensive patients without BRVO). We, therefore, recommended the potential use of MPV as a prognostic biomarker in patients with BRVO.

BRVO is a retinal vascular disease entity with an incidence of 0.5% to 1.2%. [2] Limited number of patients in our study may be due to our exclusion criteria. After detailed physical examination, patients with suspected systemic illnesses excluded from the study, except systemic hypertension. Moreover, we excluded BRVO patients with morbid obesity (Body mass index ≥ 35 kg/m 2 ). Since most of the patients with BRVO are older and coincidence of systemic diseases is quite common in these individuals, we thought that 40 patients who provided our inclusion criteria could not be underestimated for a simple preliminary study. However, further studies with a larger sample are necessary to confirm our preliminary findings. In addition to this, other inflammatory markers in routine hemogram test including red cell distribution width, neutrophil lymphocyte ratio, plateletcrit, and platelet lymphocyte ratio should be tested in future studies in patients with BRVO.



 
  References Top

1.
Onder HI, Kilic AC, Kaya M, Bulur S, Onder E, Tunc M. Relation between platelet indices and branch retinal vein occlusion in hypertensive patients. Indian J Ophthalmol 2013;61:160-2.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.
Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: Epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina 2013;33:901-10.  Back to cited text no. 2
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed429    
    Printed7    
    Emailed0    
    PDF Downloaded109    
    Comments [Add]    

Recommend this journal